Acd Injection, Solution
NDC Package 14537-810-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Acd (citric acid monohydrate, dextrose monohydrate, and trisodium citrate dihydrate) injection is anticoagulant Citrate Dextrose Solution USP (ACD) Solution A is an anticoagulant for blood collection for use only with apheresis devices. This formulation utilizes a injection, solution delivery system. Marketed by Terumo Bct, Ltd, this product is identified by NDC 14537-810 and is authorized under FDA application BA010228.

Identification & Billing

NDC Package Code
14537-810-12
Package Description
12 BAG in 1 CARTON / 750 mL in 1 BAG (14537-810-75)
Product Code
14537-810
11-Digit Billing Format
14537081012

Clinical Specifications

Proprietary Name
Acd A
Non-Proprietary Name
Citric Acid Monohydrate, Dextrose Monohydrate, And Trisodium Citrate Dihydrate
Substance Name
Citric Acid Monohydrate; Dextrose Monohydrate; Trisodium Citrate Dihydrate
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Anticoagulant Citrate Dextrose Solution USP (ACD) Solution A is an anticoagulant for blood collection for use only with apheresis devices. [See Dosage and Administration (2).]

Regulatory & Marketing

Labeler Name
Terumo Bct, Ltd
Product Type
Human Prescription Drug
FDA Application #
BA010228
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 14537-810-12 identifies a specific commercial package of 12 bag in 1 carton / 750 ml in 1 bag (14537-810-75) of Acd A, a human prescription drug labeled by Terumo Bct, Ltd. This injection, solution is formulated for intravenous use and contains citric acid monohydrate; dextrose monohydrate; trisodium citrate dihydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Terumo Bct, Ltd on June 01, 2026. The current certification is valid through December 31, 2027.

How is this Terumo Bct, Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 14537081012. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
14537-810-12
11-Digit CMS (5-4-2)
14537-0810-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.